September 17, 2026
1 min read

FDA drops warning letter on Bausch & Lomb, citing contamination concerns

The FDA issued a warning letter to Bausch & Lomb over contamination concerns at its Tampa, Florida, facility that produces prescription and over-the-counter eye medications.

Leave a Reply

Your email address will not be published.

Previous Story

SNA calls for federal help as school meal costs mount

Next Story

STAT+: The FDA’s rebuilding effort is running into a new challenge

Previous Story

SNA calls for federal help as school meal costs mount

Next Story

STAT+: The FDA’s rebuilding effort is running into a new challenge

Latest from Blog

Go toTop